Ranexa™ (ranolazine extended-release tablets) was approved by USDA for marketing on January 27, 2005 and is now being shipped to pharmaceutical wholesalers.
CV Therapeutics, the drug’s manufacturer is anticipating that Ranexa™ will be available in pharmacies by the end of this month. The approved product labeling of Ranexa™ states that it is indicated for the treatment of chronic angina and should be used in combination with amlodipine, beta-blockers or nitrates. For complete product info: safety and dosage, visit www.ranexa.com
Source: CV Therapeutics Press Release
.jpg)
» Ranexa™, Now Available in U.S. Pharmacies from ThePharmVoice
CV Therapeutic Inc.’s Ranexa™ is now available in pharmacies and is now being promoted to cardiology specialists in the United States. Ranexa™ (ranolazine extended-release tablets) is approved as second-line treatment for chronic angi... [Read More]
Tracked on: March 27, 2006 2:15 AM | Permalink to Trackback